This course explores the revived research into psychedelics like MDMA, psilocybin and cannabis for treating PTSD, anxiety, depression and more, including outcomes, therapeutic mechanisms and safe integration with psychotherapy.
Pesi
English
Next cohort: Jul 13, 2026
6 Hours
Start date: July 13, 2026
This six-hour course (recording from the 30th International Trauma Conference) explores the therapeutic potential of psychedelics and cannabis for treating PTSD, anxiety, depression and more.
Learn about revived research into MDMA, psilocybin, and marijuana after decades of prohibition. Discover how psychedelic-assisted psychotherapy facilitates trauma healing, with lasting benefits seen in MAPS-sponsored MDMA trials. Review outcomes from psilocybin studies for cancer patients facing end-of-life distress. Examine the promise and limitations of cannabis for mental health. Gain perspectives from pioneering researchers and clinicians conducting psychedelic therapy.
Through video modules and discussions, develop knowledge of how psychedelics reduce defensive reactions, allowing deeper processing of emotions and memories. Consider how these treatments integrate with contemporary psychotherapy. Earn up to 6 CE credits distinguishing between psychedelics, weighing risks and benefits, and preparing to advise clients about safe, effective psychedelic-assisted healing.
Mental health, rehab, and healthcare professionals, including therapists and psychologists.
PESI is a leading continuing education provider for mental health professionals, offering accredited online courses on psychedelic-assisted therapies including MDMA, psilocybin, ketamine, and microdosing, covering clinical frameworks, ethics, harm reduction, and client communication for therapists, counselors, nurses, and psychiatrists. Their trainings help clinicians build competence in this rapidly emerging therapeutic field and earn CE credits required for licensure.
By Double Blind
This article examines how ketamine clinics may serve as a model for future legal psychedelic therapy, especially for MDMA and psilocybin. It compares clinic models, regulation, and the role of psychotherapy in treatment delivery.
By CIIS
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
Next cohort: Jun 1, 2026
By Phoenix Academy
Online course in clinical psychedelic therapy covering preparation, dosing, safety, integration, and work with co-therapists and clients. Includes videos, interactive content, quizzes, and course documents.